In a recent study, researchers compared the effects of a high-dose trivalent influenza vaccine with a standard-dose vaccine in adults 65 years of age or older.
A study shows that live attenuated influenza vaccines increase immune responses in children, and could potentially lead to universal influenza vaccines.
In this respiratory disease roundup, researchers highlight the efficacy of clesrovimab in preventing respiratory syncytial virus infections in infants, the influenza vaccine's updated formulation this virus...
A recent study examined the relationship between influenza vaccination and the risk of hospitalization for community-acquired influenza-associated pneumonia.
